Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA clears PCI's on-site oxygen generators

This article was originally published in Clinica

Executive Summary

Oxygen generators developed by Riverside, California-based gas separation specialist PCI have received US 510(k) clearance. The devices, known as deployable oxygen concentrator systems, or DOCS, generate and deliver 93%-pure oxygen. They can now be used: in disaster relief, crisis response or humanitarian relief situations where bottled or bulk oxygen is not readily available; as hospital backup systems; in local emergencies where the primary oxygen supply has been rendered unusable; to fill high-pressure oxygen cylinders for use in remote locations or for ambulatory patient use; or by military personnel in peacetime or wartime support of the Armed Forces. PCI is the only firm that currently has FDA clearance for sale of US Pharmacopeia (USP) 93 Medical Oxygen generators with an output of over 40 litres per minute for use outside of the military.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT096685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel